NASOALDO

Medicinal product

(Invented) name

NASOALDO

Active substance (s)

Mometazono furoatas

Strength

50 µg/dozėje

Pharmaceutical form

nosies purškalas (suspensija)

Route (s) of administration

vartoti į nosį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R01AD09, Mometasone

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-09-11

Date of renewal

Documents

3589_NASOALDO_PIL.docx

3589_NASOALDO_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Kiekvienoje pompos išpurškiamoje dozėje (0,1 ml) yra:	1 dozėje
Mometazono furoatas	50 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122269	108381	1108381	buteliukas	140 dozių N1		Receptinis	LT/L/26/3589/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-09-11	Registruotas